Massimo Tempestilli

Statistics

Publications

Citations

872

H-Index

Active since

2005

Affiliations

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

Center for Prevention and Treatment of Infections

Sapienza University of Rome

University of Turin

Massimo Tempestilli is an author at Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani specializing in antiretroviral therapy, pharmacology, and life sciences.

ORCID

Publications per year

2005–2023

Publications

Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome

Alessandra Sacchi, Germana Grassi, Veronica Bordoni et al. · Cell Death and Disease · 2020 · 117 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19

Massimo Tempestilli, Priscilla Caputi, Valeria Avataneo et al. · Journal of Antimicrobial Chemotherapy · 2020 · 112 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

Cross-subtype Immunity against Avian Influenza in Persons Recently Vaccinated for Influenza

Cristiana Gioia, Concetta Castilletti, Massimo Tempestilli et al. · Emerging infectious diseases · 2008 · 102 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Granulocytic Myeloid Derived Suppressor Cells Expansion during Active Pulmonary Tuberculosis Is Associated with High Nitric Oxide Plasma Level

Sary El Daker, Alessandra Sacchi, Massimo Tempestilli et al. · PLoS ONE · 2015 · 72 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vγ9Vδ2 T cells

Fabrizio Poccia, Cristiana Gioia, Federico Martini et al. · AIDS · 2009 · 60 citations

Life Sciences, Immunology, Pharmacotherapy +17

1–5 of 24